-
When discussing contraceptive options with your female patients, what choices are available at your facility? If they include the contraceptive patch (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) and the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ), you join the majority of respondents to the 2003 Contraceptive Technology Update Contraception Survey.
-
A total of 215 providers participated in the 2003 Contraceptive Technology Update Contraception Survey, which monitors contraceptive trends and family planning issues among readers.
-
The next patient on your schedule is a 41-year-old woman who smokes 12-15 cigarettes a day. She would like to use combined oral contraceptives (OCs). Will she leave your office with a prescription for the Pill?
-
Just six years ago, a national report asked, Is the secret getting out? when it comes to emergency contraception (EC).1 If results of the 2003 Contraceptive Technology Update Contraception Survey are any indication, ECs message now is being heard loud and clear.
-
ACNM web site offers breast-feeding resources; New condom now available from Trojan; New Arabic web site offers EC information
-
Seasonale (Barr Laboratories, Pomona, NY), the first extended-cycle oral contraceptive (12 weeks continuous daily active pill followed by a one-week inactive pill) approved by the Food and Drug Administration (FDA) is expected to become clinically available by the end of this month.
-
Staphylococcus lugdunensis, in contrast to the other skin and mucus membrane-colonizing coagulase-negative staphylococci, has virulence factors that closely resemble those of Staphylococcus aureus and consequently causes similar aggressively destructive infections.
-
Pulsed-dose intravenous methylprednisolone added to the conventional treatment of IVIG and high-dose aspirin, resulted in faster resolution of fever and lower ESR, CRP, and levels of IgA in children with Kawasaki disease.
-
Synopsis: Copper silver ionization in potable waters was found to be highly effective in reducing environmental Legionella colonization and preventing nosocomial Legionnaires disease over prolonged time periods.
-
Synopsis: Treatment of CAP with 750 mg of levofloxacin daily for 5 days was as effective as a 10-day course of 500 mg daily.
